Miebo for Dry Eye
(Sonoran Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry eye disease (DED)
Are You a Good Fit for This Trial?
This trial is for adults with mild to moderate dry eye disease who are planning routine LASIK surgery. Participants must not have had prior eye surgeries, active eye allergies or infections, recent use of certain eye treatments, or abnormal corneas. Pregnant or nursing women and those unable to follow study instructions cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Miebo instilled four times per day to each eye perioperatively
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Miebo
Trial Overview
The study tests Miebo eye drops (used four times daily) before and after LASIK surgery in people with dry eyes. It aims to see if Miebo helps reduce dryness caused by the procedure compared to dryness levels before treatment.
How Is the Trial Designed?
1
Treatment groups
Active Control
Miebo instilled four times per day to each eye
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vance Thompson Vision
Lead Sponsor
Bausch & Lomb Incorporated
Industry Sponsor
Dr. Christina Ackermann
Bausch & Lomb Incorporated
Chief Medical Officer since 2023
MD from Harvard Medical School
Brent Saunders
Bausch & Lomb Incorporated
Chief Executive Officer since 2023
BA from the University of Pittsburgh, JD and MBA from Temple University
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.